Skip to main content

Table 1 Clinical characteristics of participants included in the biomarker analyses

From: Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso

 

Total (n = 160)

Cases (n = 79)

Controls (n = 81)

p value

Age in years, mean (SD)

25.4 (± 6.0)

25.2 (± 6.2)

25.7 (± 5.8)

0.560

Preeclampsia

0

0

0

Hemoglobin at delivery in g/dL mean (SD)

12.0 (1.5)

11.9 (1.6)

12.1 (1.4)

0.527

Gravidity

 Primigravidae % (n)

22.5 (36)

25.3 (20)

19.8 (16)

0.371

 Secundigravidae % (n)

17.5 (28)

16.5 (13)

18.5 (15)

0.784

 Multigravidae % (n)

60 (96)

58.2 (46)

61.7 (50)

0.595

Infected at first visit

 By microscopy % (n)

31.3 (50/160)

30.4 (24/79)

32.1 (26/81)

0.798

 By real-time PCR % (n)

47.8 (76/159)

48.7 (38/78)

46.9 (38/81)

0.799

Infected at delivery

 By microscopy, % (n)

22.5 (36/160)

43.0 (34/79)

2.5 (2/81)

<0.001

 By placental biopsy, % (n)

8.2 (11/134)

11.9 (8/67)

4.5 (3/67)

0.165

 Birthweight in kg, mean (SD)

3.01 (0.57)

2.94 (0.62)

3.07 (0.52)

0.130

 Low birth weight < 2500 g, % (n)

9.5 (15/158)

7.7 (6/78)

11.3 (9/80)

0.410

 IPTp-SP doses, median (IQR)

3 (2–4)

3 (2–4)

3 (2–3)

0.627